Interested in participating?
We are looking for participants for the following studies. If you are interested, please email Hamida with "Interest in study participation" in the subject line.
This phase II randomized double-blind clinical trial is designed to evaluate the therapeutic effects of repetitive Transcranial Permanent Magnet Stimulator (rTPMS) in improving neurogenic overactive bladder (NOAB) in multiple sclerosis (MS) patients with a commercially available device. The target population for this study is adult patients (≥ 18 years old) with clinically stable MS who have been experiencing NOAB symptoms for more than 3 months. If you are interested, please contact us!
Artificial Urinary Sphincter Clinical Outcomes
The AMS 800 Artificial Urinary Sphincter™ (AUS) is a device used to treat stress urinary incontinence in men. Though it has received official market approval since 1982, incremental technological advancements have been implemented to the device, along with the creation of additional tools to assist with the implantation procedure. This study evaluates the AMS 800 and the AMS tools in men with primary stress urinary incontinence. We are looking for male participants over 18 years of age who plan to undergo an AUS implantation procedure at Houston Methodist Hospital.
Bulbocavernosus Reflex (BCR) Stimulation in Individuals with Spinal Cord Injury and Healthy Participants
Functional MRI (fMRI) can be used to study the brain, but it's difficult to study the spinal cord. A new low-cost device was developed to study the spinal cord's neural pathways controlling bladder function by tapping the suprapubic region instead of inducing the bulbocavernosus reflex through more immodest means. The device has received clearance for testing in healthy and injured participants and can help researchers explore mechanisms controlling urinary, digestive, or sexual function in the sacral spinal cord region.